| 10988433 |
Cyclohexyl GPR40 agonists for the treatment of type II diabetes |
Hui Huang, James C. Lanter, Sanath K. Meegalla |
2021-04-27 |
$133,106,000 |
| 10662170 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Gee-Hong Kuo, Shyh-Ming Yang, Yue-Mei Zhang |
2020-05-26 |
$121,919,000 |
| 10131648 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Gee-Hong Kuo, Shyh-Ming Yang, Yue-Mei Zhang |
2018-11-20 |
$77,240,000 |
| 10106553 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Sanath K. Meegalla, Hui Huang, Michael Winters |
2018-10-23 |
$106,668,000 |
| 9920040 |
GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Sanath K. Meegalla |
2018-03-20 |
$160,053,000 |
| 9908873 |
GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Sanath K. Meegalla |
2018-03-06 |
$124,445,000 |
| 9856245 |
GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Sanath K. Meegalla |
2018-01-02 |
$167,355,000 |
| 9790198 |
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Gee-Hong Kuo, Shyh-Ming Yang, Yue-Mei Zhang |
2017-10-17 |
$73,207,000 |
| 9718820 |
Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators |
Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, Daniel Parks, William J. Parsons +2 more |
2017-08-01 |
$87,962,000 |
| 9688642 |
Substituted pyrazines as GPR40 agonists |
Sanath K. Meegalla, Hui Huang |
2017-06-27 |
$57,687,000 |
| 9409915 |
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, Daniel Parks, William J. Parsons +2 more |
2016-08-09 |
$153,043,000 |
| 9249163 |
PDE10a inhibitors for the treatment of type II diabetes |
Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson, Yu-Kai Lee +4 more |
2016-02-02 |
$67,544,000 |
| 9193736 |
PDE 10a inhibitors for the treatment of type II diabetes |
Sanath K. Meegalla, Carl R. Illig, Jinsheng Chen, Kenneth Wilson, Yu-Kai Lee +4 more |
2015-11-24 |
$122,826,000 |
| 9067898 |
Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes |
Carl R. Illig, Xuqing Zhang |
2015-06-30 |
$80,032,000 |
| 9023846 |
Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, Daniel Parks, William J. Parsons +2 more |
2015-05-05 |
$77,894,000 |
| 8796256 |
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators |
Gilles Bignan, Wing S. Cheung, Micheal Gaul, Hui Huang, Xun Li +5 more |
2014-08-05 |
$40,134,000 |
| 8680098 |
Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
Raul Calvo, Jinsheng Chen, Sanath K. Meegalla, Daniel Parks, William J. Parsons +2 more |
2014-03-25 |
$79,525,000 |
| 8232409 |
Heterocyclic benzimidazoles as TRPM8 modulators |
Daniel Parks, William H. Parsons, Sanath K. Meegalla, Carl R. Illig, Shelley K. Ballentine |
2012-07-31 |
$66,960,000 |
| 8217060 |
Benzimidazole derivatives useful as TRP M8 receptor modulators |
Raul Calvo, Sanath K. Meegalla |
2012-07-10 |
$57,830,000 |
| 7951829 |
Benzimidazole modulators of VR1 |
Scott L. Dax, William H. Parsons, Michael Brandt, Raul Calvo, Sharmila Patel +8 more |
2011-05-31 |
$104,348,000 |
| 7829584 |
Pyridines and pyridine N-oxides as modulators of thrombin |
Tianbao Lu, Huaping Hu, Xizhen Zhu, Christopher A. Teleha, Kevin D. Kreutter |
2010-11-09 |
$66,514,000 |
| 7790724 |
c-fms kinase inhibitors |
Nand Baindur, Benjamin Brandt, Naresh Chadha, Raymond J. Patch, Davoud Asgari +1 more |
2010-09-07 |
$62,281,000 |
| 7728003 |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
Hui Huang, Hu Huaping, Renee Louise Desjarlais |
2010-06-01 |
$48,924,000 |
| 7705151 |
1,6 Naphthridines useful as inhibitors of SYK kinase |
Charles Cywin, Scott Jakes, Joachim Heider, Mark Bobko, Renee L. Des Jarlais +3 more |
2010-04-27 |
|
| 7678911 |
1,6 naphthyridines useful as inhibitors of SYK kinase |
Charles Cywin, Scott Jakes, Joachim Heider, Mark Bobko, Renee L. Des Jarlais +3 more |
2010-03-16 |
|
